AHA/ACC guidelines for secondary prevention for ... [Circulation. 2006] - PubMed

loading

AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. [J Am Coll Cardiol. 2006]
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.
AHA, ACC, National Heart, Lung, and Blood Institute, Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, et al. J Am Coll Cardiol. 2006 May 16; 47(10):2130-9.
Review [Primary and secondary prevention of coronary artery disease]. [Fukuoka Igaku Zasshi. 2003]
Review [Primary and secondary prevention of coronary artery disease].
Mohri M. Fukuoka Igaku Zasshi. 2003 Mar; 94(3):43-7.
Review [Hypertension and arteriopathy]. [Rev Med Liege. 2002]
Review [Hypertension and arteriopathy].
Krzesinski JM. Rev Med Liege. 2002 Jun; 57(6):370-4.
Review Optimal medical management of peripheral arterial disease. [Vasc Endovascular Surg. 2006]
Review Optimal medical management of peripheral arterial disease.
Rice TW, Lumsden AB. Vasc Endovascular Surg. 2006 Aug-Sep; 40(4):312-27.
Review [Coronary artery disease in patients with diabetes mellitus and its treatment]. [Nihon Naika Gakkai Zasshi. 2002]
Review [Coronary artery disease in patients with diabetes mellitus and its treatment].
Teramoto T. Nihon Naika Gakkai Zasshi. 2002 Mar 20; 91 Suppl:94-9.

Cardioprotective medication use and risk factor control among US adults with unrecognized myocardial infarction: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. [Vasc Health Risk Manag. 2013]
Cardioprotective medication use and risk factor control among US adults with unrecognized myocardial infarction: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
Levitan EB, Gamboa C, Safford MM, Rizk DV, Brown TM, Soliman EZ, Muntner P. Vasc Health Risk Manag. 2013; 9:47-55. Epub 2013 Feb 5.
Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis. [J Am Heart Assoc. 2012]
Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis.
Jones PH, Nair R, Thakker KM. J Am Heart Assoc. 2012 Dec; 1(6):e001800. Epub 2012 Dec 19.
Home-based cardiac rehabilitation is an attractive alternative to no cardiac rehabilitation for elderly patients with coronary heart disease: results from a randomised clinical trial. [BMJ Open. 2012]
Home-based cardiac rehabilitation is an attractive alternative to no cardiac rehabilitation for elderly patients with coronary heart disease: results from a randomised clinical trial.
Oerkild B, Frederiksen M, Hansen JF, Prescott E. BMJ Open. 2012; 2(6). Epub 2012 Dec 18.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

AHA/ACC guidelines for secondary prevention for patients with coronary and other...
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.
Circulation. 2006 May 16 ;113(19):2363-72.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed